Mon to Fri 08h00 to 16h30 ( UTC +2)

Mon to Fri 08h00 to 16h30 ( UTC +2)

Pharmaceutical IP and competition law in South Africa: overview

  1. Home
  2. /
  3. Intellectual Property
  4. /
  5. Patents
  6. /
  7. Pharmaceutical IP and competition law in South Africa: overview

Published Date: May 12, 2020

Pharmaceutical IP and competition law in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie

A Q&A guide to pharmaceutical IP and competition law in South Africa.

The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.

To read the full Q&A, visit Thomson Reuters Practical Law.

For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit Medicinal product regulation and product liability in South Africa: overview.

Alexis Apostolidis
Partner | Head of Competition Law Group
Danie Dohmen
Partner | Patent Attorney
Jenny Pienaar
Partner | Trade Mark Attorney

How can we help you?

We have offices in Pretoria, Johannesburg, Cape Town, and Durban, please contact your nearest office for any legal enquiry or assistance.

Related News & Insights